Man Group
VYGR icon

Man Group’s Voyager Therapeutics VYGR Stock Holding History

Man Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-41,200
Closed -$234K – 2391
2024
Q4 		$234K Buy
+41,200
New +$266K ﹤0.01% 1841
2024
Q3 		– Sell
-14,957
Closed -$118K – 2228
2024
Q2 		$118K Sell
14,957
-58,272
-80% -$489K ﹤0.01% 1951
2024
Q1 		$682K Buy
73,229
+57,062
+353% +$482K ﹤0.01% 1679
2023
Q4 		$136K Buy
+16,167
New +$117K ﹤0.01% 1957
2023
Q3 		– Hold
0
– – – 1789
2023
Q1 		– Sell
-21,077
Closed -$168K – 1752
2022
Q4 		$129K Buy
+21,077
New +$120K ﹤0.01% 1865
2022
Q2 		– Sell
-20,602
Closed -$157K – 2432
2022
Q1 		$157K Buy
+20,602
New +$91.9K ﹤0.01% 1987
2021
Q2 		– Sell
-17,200
Closed -$81K – 2106
2021
Q1 		$81K Sell
17,200
-106,160
-86% -$724K ﹤0.01% 1806
2020
Q4 		$882K Buy
123,360
+500
+0.4% +$4.81K ﹤0.01% 1442
2020
Q3 		$1.31M Sell
122,860
-2,100
-2% -$24.6K 0.01% 1317
2020
Q2 		$1.58M Sell
124,960
-11,978
-9% -$139K 0.01% 1143
2020
Q1 		$1.25M Buy
136,938
+18,975
+16% +$218K 0.01% 1051
2019
Q4 		$1.65M Buy
117,963
+51,163
+77% +$744K 0.01% 1380
2019
Q3 		$1.15M Buy
+66,800
New +$1.4M ﹤0.01% 1393
2019
Q1 		– Sell
-11,141
Closed -$105K – 2080
2018
Q4 		$105K Sell
11,141
-1,793
-14% -$23K ﹤0.01% 1853
2018
Q3 		$245K Buy
+12,934
New +$248K ﹤0.01% 1990

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group's VYGR Position: Q1 2025 in Review

Man Group sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 41,200 shares — an estimated $234K sold.

Man Group first reported a position in VYGR in Q3 2018 and held it in 15 quarters. The position peaked at $1.65M in Q4 2019. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Man Group reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Man Group sold 41,200 Voyager Therapeutics shares in Q1 2025, an estimated $234K.
  • Man Group first reported a position in Voyager Therapeutics in Q3 2018 and held it in 15 quarters.
  • Man Group's Voyager Therapeutics position peaked at $1.65M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Man Group's 13F filing for Q1 2025, filed 15 May 2025.